A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
about
Clathrin is required for the function of the mitotic spindleTFEB at a glanceBreakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer typesAmplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancersDiagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese populationMolecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressivenessMagnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasisThe mitotic arrest deficient protein MAD2B interacts with the clathrin light chain A during mitosis.Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.Requirement of clathrin heavy chain for p53-mediated transcription.Genomic analysis of fibrolamellar hepatocellular carcinoma.Alveolar soft-part sarcoma in the sacrum: a case report and review of the literature.Diagnostic approach to eosinophilic renal neoplasmsClinicopathological features of Xp11.2 translocation renal cell carcinoma.t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed casesHypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumMolecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersNewly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant articleXp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.The cellular functions of clathrin.Translocation renal cell carcinomas in adults: a single-institution experience.Perivascular epithelioid cell neoplasm of the urinary bladder in an adolescent: a case report and review of the literature.A case of renal cancer with TFE3 gene fusion in an elderly man. Clinical, radiological and surgical findings.Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma.Hypoxia induces TFE3 expression in head and neck squamous cell carcinomaMolecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE)Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study.Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.
P2860
Q24300939-04F433F7-0953-4114-BD2E-64C88348AECCQ28074375-662ECA16-CF02-4CA1-B644-0BF121F5D447Q28486949-8DD16D13-59D3-4B5B-BBF2-D7608C8E727FQ28728499-ABDC397C-CCA2-4B1C-8EA3-F53FF72A0D04Q31046172-6AF58BB7-39DA-4F62-957D-ADE15C618B12Q33274854-5DE2C549-53E4-4FA6-9A5B-BC8708AFCB31Q33315301-74318773-69E6-49B3-8A41-A357F8D1BD32Q33401272-F7B7A95C-A49B-4ACA-BF44-26EA50EE312CQ33704636-F443669A-768B-4B30-B2C5-2D3F34EA12E5Q33754360-19AB916D-2E4C-4041-8AA5-325D756793D9Q33756641-48CE65BC-5A67-4624-AA0E-FCCE6C9C087AQ33770098-82370C73-6665-43B1-8FE3-1A8CC270F222Q33874474-01DC5CE6-F734-405C-B6D8-CAEDB2A25862Q34194075-E804139D-4884-4935-B3FE-EE5AAF0DCF7DQ34206517-B730CF8A-A07F-444F-BC47-17918644E379Q34638089-4E175C0E-EB21-43CD-93A0-E29B6A314244Q34650413-B8612811-A74F-4BAF-B286-1EFD7BDFBE7DQ34673400-03EC517C-51D9-472D-9AD9-41539B07FC54Q35007669-41E83174-0A28-40E3-B4E6-2E0F86C6443AQ35155653-49B9C868-7191-48CC-A534-1CE60B93A935Q35164815-10C9577F-E453-46BD-9F65-06BE60E06EDFQ35207508-6B25DA02-5478-430F-821A-2F42450109F3Q35470449-29A2D96F-E337-46C3-A93B-D15623AA4FC4Q35632133-1E159486-4F5B-403A-9885-66D3A3B528F4Q35636323-2D73F216-C95B-4D3A-909C-382CA3B080ACQ36001179-FD517C23-5686-4664-8283-9C1A9388E448Q36151526-23DDDE2E-9862-4362-86A6-4C9B2F8FD124Q36253663-47BDB3C6-06E2-4DE8-B951-0781EFD4469CQ36446169-DEF5C866-D5BF-4BA5-AB3F-E3905E0B979BQ36478282-D59E84C7-AF07-40DC-9A18-2469A6747B55Q36481657-A158A16C-27B8-4112-BD76-874ED9803C2AQ36524121-760DD77D-713A-4D64-9D58-4230AFE3F259Q36733508-F73F62E4-3B22-455F-9310-CCC2DB40C7F8Q36741509-6E4E118D-56CA-4BF3-8B38-DD0EBB548B67Q36998335-46861AD5-3B49-4B15-8158-0A7A0CF7BDD3Q37000269-0DEF8B83-68FC-47FB-BC41-AEFEA2849BE0Q37212701-154FF8E6-B7E8-43FA-81C1-166FC0711FB5Q37269202-5360417C-6253-4A56-A11A-0DC87FEF94D5Q37452237-2CAC4A74-53F0-411B-A668-084045561BCDQ37541507-FD0966E9-69FD-492E-8304-2A98751CA5C1
P2860
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t
@nl
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
@en
type
label
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t
@nl
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
@en
prefLabel
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t
@nl
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
@en
P2093
P2860
P356
P1433
P1476
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
@en
P2093
Jean-Christophe Fournet
Jérôme Couturier
Man Yee Lui
Pedram Argani
Raymonde Bouvier
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206686
P407
P50
P577
2003-08-01T00:00:00Z